Matches in SemOpenAlex for { <https://semopenalex.org/work/W2338974767> ?p ?o ?g. }
- W2338974767 endingPage "e0153497" @default.
- W2338974767 startingPage "e0153497" @default.
- W2338974767 abstract "Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of diseases from simple steatosis to non-alcoholic steatohepatitis, with approximately 20% risk of progressing to fibrosis and cirrhosis. The aim of this study was to compare the relative expression levels of circulating miR-21, miR-34a, miR-122, miR-125b and miR-375 between healthy controls and NAFLD patients, and to assess the feasibility of microRNAs as potential biomarkers for NAFLD. A cross-sectional study was conducted to evaluate circulating serum miRNAs as potential diagnostic markers for NAFLD. Twenty-eight clinically diagnosed and histologically-confirmed NAFLD patients, as well as 36 healthy controls were enrolled in this study. The relative expression of serum microRNAs were calculated using the comparative cycle threshold with spiked-in C. elegans miR-39 as exogenous internal control. Serum levels of miR-34a and miR-122 were significantly higher in NAFLD patients than in healthy controls (P = <0.0001). Positive correlations were observed between serum miR-34a with very low density lipoprotein cholesterol (VLDL-C) and triglyceride levels. However, the expression levels of miR-34a and miR-122 did not correlate with the histological features of NAFLD. Interestingly, receiver operating characteristic (ROC) curve analysis revealed that miR-34a and miR-122 are potential markers for discriminating NAFLD patients from healthy controls with an area under the curve (AUC) values of 0.781 and 0.858, respectively. Serum levels of miR-34a and miR-122 were found to be significantly higher among NAFLD patients, and were positively correlated with VLDL-C and triglyceride levels. Thus, circulating miR-34a and miR-122 can be used as potential biomarkers for discriminating NAFLD patients from healthy controls. Larger cohorts are required to validate the utility of miR-34a and miR-122 in monitoring liver injury." @default.
- W2338974767 created "2016-06-24" @default.
- W2338974767 creator A5010934719 @default.
- W2338974767 creator A5048495918 @default.
- W2338974767 creator A5056102345 @default.
- W2338974767 creator A5071969382 @default.
- W2338974767 date "2016-04-14" @default.
- W2338974767 modified "2023-10-13" @default.
- W2338974767 title "Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease" @default.
- W2338974767 cites W1681077791 @default.
- W2338974767 cites W1825697469 @default.
- W2338974767 cites W1959917743 @default.
- W2338974767 cites W1964787482 @default.
- W2338974767 cites W1965417115 @default.
- W2338974767 cites W1971169411 @default.
- W2338974767 cites W1972492327 @default.
- W2338974767 cites W1989277040 @default.
- W2338974767 cites W1990726393 @default.
- W2338974767 cites W1992941735 @default.
- W2338974767 cites W1996415443 @default.
- W2338974767 cites W1998404710 @default.
- W2338974767 cites W2006041438 @default.
- W2338974767 cites W2014946489 @default.
- W2338974767 cites W2019900254 @default.
- W2338974767 cites W2020176664 @default.
- W2338974767 cites W2027744584 @default.
- W2338974767 cites W2040109162 @default.
- W2338974767 cites W2048091871 @default.
- W2338974767 cites W2049047145 @default.
- W2338974767 cites W2064085622 @default.
- W2338974767 cites W2068053039 @default.
- W2338974767 cites W2078220428 @default.
- W2338974767 cites W2093894988 @default.
- W2338974767 cites W2104956231 @default.
- W2338974767 cites W2106946385 @default.
- W2338974767 cites W2106985304 @default.
- W2338974767 cites W2107277218 @default.
- W2338974767 cites W2114570899 @default.
- W2338974767 cites W2115093090 @default.
- W2338974767 cites W2120600590 @default.
- W2338974767 cites W2124756133 @default.
- W2338974767 cites W2134896806 @default.
- W2338974767 cites W2142844314 @default.
- W2338974767 cites W2160211389 @default.
- W2338974767 cites W2161222316 @default.
- W2338974767 cites W2166321004 @default.
- W2338974767 cites W216833258 @default.
- W2338974767 cites W1964184380 @default.
- W2338974767 doi "https://doi.org/10.1371/journal.pone.0153497" @default.
- W2338974767 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4831793" @default.
- W2338974767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27077736" @default.
- W2338974767 hasPublicationYear "2016" @default.
- W2338974767 type Work @default.
- W2338974767 sameAs 2338974767 @default.
- W2338974767 citedByCount "101" @default.
- W2338974767 countsByYear W23389747672016 @default.
- W2338974767 countsByYear W23389747672017 @default.
- W2338974767 countsByYear W23389747672018 @default.
- W2338974767 countsByYear W23389747672019 @default.
- W2338974767 countsByYear W23389747672020 @default.
- W2338974767 countsByYear W23389747672021 @default.
- W2338974767 countsByYear W23389747672022 @default.
- W2338974767 countsByYear W23389747672023 @default.
- W2338974767 crossrefType "journal-article" @default.
- W2338974767 hasAuthorship W2338974767A5010934719 @default.
- W2338974767 hasAuthorship W2338974767A5048495918 @default.
- W2338974767 hasAuthorship W2338974767A5056102345 @default.
- W2338974767 hasAuthorship W2338974767A5071969382 @default.
- W2338974767 hasBestOaLocation W23389747671 @default.
- W2338974767 hasConcept C126322002 @default.
- W2338974767 hasConcept C134018914 @default.
- W2338974767 hasConcept C146304588 @default.
- W2338974767 hasConcept C203014093 @default.
- W2338974767 hasConcept C2522874641 @default.
- W2338974767 hasConcept C2776175330 @default.
- W2338974767 hasConcept C2776408679 @default.
- W2338974767 hasConcept C2777214474 @default.
- W2338974767 hasConcept C2778096610 @default.
- W2338974767 hasConcept C2778163477 @default.
- W2338974767 hasConcept C2778772119 @default.
- W2338974767 hasConcept C2778913445 @default.
- W2338974767 hasConcept C2779134260 @default.
- W2338974767 hasConcept C2779478299 @default.
- W2338974767 hasConcept C53673613 @default.
- W2338974767 hasConcept C71924100 @default.
- W2338974767 hasConcept C90924648 @default.
- W2338974767 hasConceptScore W2338974767C126322002 @default.
- W2338974767 hasConceptScore W2338974767C134018914 @default.
- W2338974767 hasConceptScore W2338974767C146304588 @default.
- W2338974767 hasConceptScore W2338974767C203014093 @default.
- W2338974767 hasConceptScore W2338974767C2522874641 @default.
- W2338974767 hasConceptScore W2338974767C2776175330 @default.
- W2338974767 hasConceptScore W2338974767C2776408679 @default.
- W2338974767 hasConceptScore W2338974767C2777214474 @default.
- W2338974767 hasConceptScore W2338974767C2778096610 @default.
- W2338974767 hasConceptScore W2338974767C2778163477 @default.
- W2338974767 hasConceptScore W2338974767C2778772119 @default.
- W2338974767 hasConceptScore W2338974767C2778913445 @default.